| Dr Gert Hasselhof, MD | |
|
N2437 E Miner Dr, Waupaca, WI 54981-8382 | |
| (608) 475-0328 | |
| (715) 256-5452 |
| Full Name | Dr Gert Hasselhof |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | N2437 E Miner Dr, Waupaca, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043289473 | NPI | - | NPPES |
| 32071200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34927 (Wisconsin) | Secondary |
| 207P00000X | Emergency Medicine | 34927 (Wisconsin) | Primary |
| Entity Name | Moundview Memorial Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710939533 PECOS PAC ID: 1355250432 Enrollment ID: O20031121000846 |
News Archive
The Health and Technology District in Surrey, B.C. is partnering with Halo Health, Canada's first angel network for healthcare, on a new collaboration to expand and support health-tech innovations and entrepreneurs.
BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 5 days ago
| Entity Name | Reedsburg Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891796710 PECOS PAC ID: 9830008259 Enrollment ID: O20031208000083 |
News Archive
The Health and Technology District in Surrey, B.C. is partnering with Halo Health, Canada's first angel network for healthcare, on a new collaboration to expand and support health-tech innovations and entrepreneurs.
BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 5 days ago
| Entity Name | Tomah Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992970453 PECOS PAC ID: 6901897016 Enrollment ID: O20040519000123 |
News Archive
The Health and Technology District in Surrey, B.C. is partnering with Halo Health, Canada's first angel network for healthcare, on a new collaboration to expand and support health-tech innovations and entrepreneurs.
BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gert Hasselhof, MD N2437 E Miner Dr, Waupaca, WI 54981-8382 Ph: (608) 475-0328 | Dr Gert Hasselhof, MD N2437 E Miner Dr, Waupaca, WI 54981-8382 Ph: (608) 475-0328 |
News Archive
The Health and Technology District in Surrey, B.C. is partnering with Halo Health, Canada's first angel network for healthcare, on a new collaboration to expand and support health-tech innovations and entrepreneurs.
BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 5 days ago
Dr. Logan Robert Gorges, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1000 Fax: 715-258-1042 | |
Dr. Amy T Kenworthy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1000 | |
Francesca L Detrana, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1000 Fax: 715-258-1632 | |
Dr. Spencer Wolf Greaves, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1000 | |
Dr. Matthew Paul Nelson, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1000 | |
Dr. Charles Conger, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1041 | |
Dale T Bertram, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 Honey Bear Ct, Waupaca, WI 54981 Phone: 608-516-9278 |